ResMed cut at Oppenheimer after Eli Lilly's tirzepatide sleep apnea data [Seeking Alpha]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Seeking Alpha
the wake of encouraging data for Eli Lilly's ( NYSE: LLY ) weight loss therapy tirzepatide in obstructive sleep apnea (OSA). The Recommended For You More Trending News Recommended For You More Trending News Related Stocks In The News Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Atossa Therapeutics Announces Updated Protocol for Clinical Trial Evaluating (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer [Yahoo! Finance]Yahoo! Finance
- Stock Split Watch: Is Eli Lilly Next? [Yahoo! Finance]Yahoo! Finance
- Walgreens cuts EPS guidance, plans to close more stores [Yahoo! Finance Canada]Yahoo! Finance Canada
- Amide Technologies Appoints Co-Founder and MIT Chemistry Professor as CEO [Yahoo! Finance]Yahoo! Finance
- Novo Will Limit Wegovy's China Launch to Avoid Global Disruption [BNN Bloomberg (Canada)]BNN Bloomberg
LLY
Earnings
- 4/30/24 - Beat
LLY
Sec Filings
- 6/28/24 - Form 144
- 6/26/24 - Form 4
- 6/25/24 - Form 4
- LLY's page on the SEC website